Risk factors for new-onset diabetes mellitus in patients receiving protease inhibitor therapy.
作者： Christine A Hughes , Richard P Cashin , Dean T Eurich , Stan Houston
DOI: 10.1155/2005/971971
关键词:
摘要: BACKGROUND: Metabolic complications including diabetes mellitus (DM) have been associated with protease inhibitor (PI) therapy. Risk factors for the development of DM are not well-defined.
hindawi.com
core.ac.uk参考文章(14)
Kathleen Mulligan, Carl Grunfeld, Viva W. Tai, Heather Algren, Miyin Pang, David N. Chernoff, Joan C. Lo, Morris Schambelan, Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes. ,vol. 23, pp. 35- 43 ,(2000) , 10.1097/00126334-200001010-00005
Georg Behrens, Andre Dejam, Hartmut Schmidt, Hans-Joachim Balks, Georg Brabant, Thorsten Körner, Matthias Stoll, Reinhold E. Schmidt, Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS. ,vol. 13, ,(1999) , 10.1097/00002030-199907090-00001
Sotirios Tsiodras, Christos Mantzoros, Scott Hammer, Matthew Samore, Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and Lipodystrophy Archives of Internal Medicine. ,vol. 160, pp. 2050- 2056 ,(2000) , 10.1001/ARCHINTE.160.13.2050
Kevin E. Yarasheski, Pablo Tebas, Catherine Sigmund, Samuel Dagogo-Jack, Alan Bohrer, John Turk, Philippe A. Halban, Philip E. Cryer, William G. Powderly, Insulin Resistance in HIV Protease Inhibitor–Associated Diabetes Journal of Acquired Immune Deficiency Syndromes. ,vol. 21, pp. 209- 216 ,(1999) , 10.1097/00126334-199907010-00005
Michael P Dubé, Deborah L Johnson, Judith S Currier, John M Leedom, Protease inhibitor-associated hyperglycaemia. The Lancet. ,vol. 350, pp. 713- 714 ,(1997) , 10.1016/S0140-6736(05)63513-1
Jessica E Justman, Lorie Benning, Ann Danoff, Howard Minkoff, Alexandra Levine, Ruth M Greenblatt, Kathleen Weber, Eva Piessens, Esther Robison, Kathryn Anastos, None, Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. Journal of Acquired Immune Deficiency Syndromes. ,vol. 32, pp. 298- 302 ,(2003) , 10.1097/00126334-200303010-00009
Ravi Walli, Oliver Herfort, Gerlinde M. Michl, Thomas Demant, Hans Jäger, Christoph Dieterle, Johannes R. Bogner, Rüidiger Landgraf, Frank D. Goebel, Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients AIDS. ,vol. 12, ,(1998) , 10.1097/00002030-199815000-00001
Morris Schambelan, Constance A. Benson, Andrew Carr, Judith S. Currier, Michael P. Dubé, John G. Gerber, Steven K. Grinspoon, Carl Grunfeld, Donald P. Kotler, Kathleen Mulligan, William G. Powderly, Michael S. Saag, Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. Journal of Acquired Immune Deficiency Syndromes. ,vol. 31, pp. 257- 275 ,(2002) , 10.1097/00126334-200211010-00001
Shruti H. Mehta, Richard D. Moore, David L. Thomas, Richard E. Chaisson, Mark S. Sulkowski, The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes. ,vol. 33, pp. 577- 584 ,(2003) , 10.1097/00126334-200308150-00005
Andrea A. Howard, Robert S. Klein, Ellie E. Schoenbaum, Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clinical Infectious Diseases. ,vol. 36, pp. 1318- 1323 ,(2003) , 10.1086/374838